CL-34Homo sapiens (Human)Cancer cell line

Also known as: CL34

🤖 AI SummaryBased on 7 publications

Quick Overview

CL-34 is a human colorectal cancer cell line used in cancer research.

Detailed Summary

CL-34 is a human colorectal cancer cell line that has been extensively studied for its molecular characteristics and drug sensitivity. It is part of a comprehensive collection of cancer cell lines used to understand the genetic and transcriptional diversity of colorectal cancers. CL-34 has been analyzed for its mutational status, gene expression profiles, and response to various therapeutic agents. The cell line is known for its utility in studying the molecular mechanisms of cancer and in developing targeted therapies. Research on CL-34 has contributed to the identification of key genetic alterations and their implications in cancer progression and treatment response.
Generated on 6/17/2025

Basic Information

Database IDCVCL_1980
SpeciesHomo sapiens (Human)
Tissue SourceColon[UBERON:UBERON_0001155]

Donor Information

Age CategoryUnknown
SexFemale
Subtype FeaturesMSI

Disease Information

DiseaseColon adenocarcinoma
LineageBowel
SubtypeColon Adenocarcinoma
OncoTree CodeCOAD

DepMap Information

Source TypeDSMZ
Source IDACH-000895_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Lys382Asnfs*40 (c.1146delA)Heterozygous-Unknown, Unknown
MutationSimpleTP53p.Ser127Pro (c.379T>C)Unspecified-Unknown, PubMed=28683746
MutationSimpleBRAFp.Val600Glu (c.1799T>A)Unspecified-PubMed=26214590
MutationSimpleAPCp.Thr1556fs*3 (c.4660_4661insA) (E1554fs)Heterozygous-from parent cell line Panc 04.03
MutationSimpleAPCp.Arg856Cys (c.2566C>T)Heterozygous-Unknown
MutationSimpleAPCp.Glu418Ter (c.1252G>T)Heterozygous-Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11
D13S317
11,13
D16S539
9,11
D18S51
12,17,18
D19S433
12,16
D21S11
30
D2S1338
19
D3S1358
12,17
D5S818
9,11
D7S820
10
D8S1179
10,11
FGA
22,24
Penta D
9,10
Penta E
7
TH01
6,7
TPOX
8,10
vWA
15,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.

van 't Veer L.J., Butte A.J., Goldstein T., Sirota M.

Nat. Commun. 10:3574.1-3574.11(2019).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Multi-omics of 34 colorectal cancer cell lines -- a resource for biomedical studies.

Myklebost O., Skotheim R.I., Sveen A., Lothe R.A.

Mol. Cancer 16:116.1-116.16(2017).

Characterization of human cancer cell lines by reverse-phase protein arrays.

Liang H.

Cancer Cell 31:225-239(2017).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets.

Linnebacher M., Cordero F., Di Nicolantonio F., Bardelli A.

Nat. Commun. 6:7002.1-7002.10(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Growing colorectal tumors: minimizing microbial and stromal competition and assessing in vitro selection pressures.

Farrell T.M., Pettengill O.S., Longnecker D.S., Cate C.C., Cohn K.H.

Cytotechnology 34:205-211(2000).

Web Resources